Study Finds Chemotherapy Unlikely to Improve Peritoneal Mesothelioma Survival
A new study from the University of Illinois suggests that patients with peritoneal mesothelioma who undergo surgery may not get…
-
-
PD-L1 Linked to Shorter Mesothelioma Survival
Mesothelioma patients who express too much of the protein PD-L1 are less likely to survive the asbestos cancer than those… -
Asbestos | Biomarkers | Diagnosis | Immune Systems | Immunotherapy | Research | Treatments | Updates
Immunotherapy for Mesothelioma: Who Are the Best Candidates?
Immunotherapy is emerging as one of the most promising new treatment approaches for a wide range of cancers, including malignant… -
Asbestos | Diagnosis | Europe | International | New Techniques | Prevention | Updates
New Assessment Identifies People at High Risk for Malignant Mesothelioma
Scottish researchers say they have come up with a better way to decide which asbestos-exposed people might benefit from mesothelioma… -
Chemotherapy | Europe | International | New Studies | Research | Symptoms | Treatments | Updates
New Chemotherapy Technique Carries Risks for Peritoneal Mesothelioma Patients
A new way of delivering chemotherapy drugs to the site of a peritoneal mesothelioma tumor has some unique benefits, but… -
Alternatives | Europe | Holistic | International | New Studies | Research | Symptoms | Treatments | Updates
Mesothelioma Patients May Benefit from ‘Aesthetic Support’
When it comes to coping with the treatment and side effects of a cancer like malignant mesothelioma, looks matter –… -
Diagnosing Mesothelioma with BAP1 Testing: Does it Work?
Tests for the presence or absence of the BAP1 tumor-suppressor protein are likely to continue to play a pivotal role… -
Multi-Modality Therapy | New Studies | Prognosis | Radiation Therapy | Research | Treatments | Updates
Tri-Modality Treatment Extends Mesothelioma Survival
New research suggests that a combination of lung-sparing surgery, highly targeted radiotherapy, and chemotherapy may bolster survival in people with… -
Platelet Count Linked to Peritoneal Mesothelioma Survival After Surgery
Peritoneal mesothelioma patients whose bodies produce too many blood platelets may not be good candidates for the treatment combination known… -
Biomarkers | Diagnosis | Europe | International | New Studies | Prognosis | Research | Updates
Diagnosing Pleural Mesothelioma with Lung Fluid: The Battle of the Biomarkers
A biomarker called soluble mesothelin related peptide (SMRP) may be a more reliable way to diagnose malignant pleural mesothelioma from…
